Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments.
Ophthalmol Ther
; 13(1): 251-266, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-37948015
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ophthalmol Ther
Year:
2024
Document type:
Article
Affiliation country:
Italy